A detailed history of Avion Wealth transactions in Moderna, Inc. stock. As of the latest transaction made, Avion Wealth holds 31 shares of MRNA stock, worth $1,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 54 42.59%
Holding current value
$1,221
Previous $6,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$63.64 - $125.14 $1,463 - $2,878
-23 Reduced 42.59%
31 $2,000
Q2 2024

Jul 26, 2024

SELL
$101.21 - $166.61 $2,024 - $3,332
-20 Reduced 27.03%
54 $6,000
Q1 2024

May 03, 2024

BUY
$85.37 - $115.44 $682 - $923
8 Added 12.12%
74 $8,000
Q4 2023

Jan 26, 2024

BUY
$69.51 - $104.43 $2,571 - $3,863
37 Added 127.59%
66 $7,000
Q3 2023

Oct 20, 2023

BUY
$96.41 - $126.61 $2,410 - $3,165
25 Added 625.0%
29 $2,000
Q2 2023

Jul 14, 2023

BUY
$118.5 - $160.53 $474 - $642
4 New
4 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.